CADTH just announced that they have resumed activities in their Scientific Advice Program and are once again accepting applications for meetings that will be held in February 2021 and beyond. All meetings will be held virtually until further notice. Please keep in mind that time periods may fill up quickly and CADTH may not be able to accommodate all requests.
The CADTH Scientific Advice Program is a voluntary, non-binding, and confidential fee-for-service consultation. Through this program, pharmaceutical companies are provided with advice on their early drug development plans from a Canadian health technology assessment perspective. For more information, please consult the CADTH website or contact CADTH directly at firstname.lastname@example.org.